These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24461963)

  • 1. Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: the Whitehall II study.
    Elbaz A; Shipley MJ; Nabi H; Brunner EJ; Kivimaki M; Singh-Manoux A
    Int J Cardiol; 2014 Mar; 172(1):96-102. PubMed ID: 24461963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terminal decline in objective and self-reported measures of motor function before death: 10 year follow-up of Whitehall II cohort study.
    Landré B; Fayosse A; Ben Hassen C; Machado-Fragua MD; Dumurgier J; Kivimaki M; Sabia S; Singh-Manoux A
    BMJ; 2021 Aug; 374():n1743. PubMed ID: 34348957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Neurocognitive and Physical Function With Gait Speed in Midlife.
    Rasmussen LJH; Caspi A; Ambler A; Broadbent JM; Cohen HJ; d'Arbeloff T; Elliott M; Hancox RJ; Harrington H; Hogan S; Houts R; Ireland D; Knodt AR; Meredith-Jones K; Morey MC; Morrison L; Poulton R; Ramrakha S; Richmond-Rakerd L; Sison ML; Sneddon K; Thomson WM; Hariri AR; Moffitt TE
    JAMA Netw Open; 2019 Oct; 2(10):e1913123. PubMed ID: 31603488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Risk Burden and Future Risk of Walking Speed Limitation in Older Adults.
    Heiland EG; Qiu C; Wang R; Santoni G; Liang Y; Fratiglioni L; Welmer AK
    J Am Geriatr Soc; 2017 Nov; 65(11):2418-2424. PubMed ID: 29124731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting late-life disability and death by the rate of decline in physical performance measures.
    Hirsch CH; Buzková P; Robbins JA; Patel KV; Newman AB
    Age Ageing; 2012 Mar; 41(2):155-61. PubMed ID: 22156556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study.
    Kaffashian S; Dugravot A; Nabi H; Batty GD; Brunner E; Kivimäki M; Singh-Manoux A
    Eur Heart J; 2011 Sep; 32(18):2326-32. PubMed ID: 21606085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early adult to midlife cardiovascular risk factors and cognitive function.
    Yaffe K; Vittinghoff E; Pletcher MJ; Hoang TD; Launer LJ; Whitmer R; Coker LH; Sidney S
    Circulation; 2014 Apr; 129(15):1560-7. PubMed ID: 24687777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study.
    Nishtala A; Himali JJ; Beiser A; Murabito JM; Seshadri S; Wolf PA; Au R
    J Alzheimers Dis; 2015; 47(1):197-204. PubMed ID: 26402768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study.
    Kaffashian S; Dugravot A; Brunner EJ; Sabia S; Ankri J; Kivimäki M; Singh-Manoux A
    Alzheimers Dement; 2013 Sep; 9(5):572-9. PubMed ID: 23199495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability.
    Newman AB; Simonsick EM; Naydeck BL; Boudreau RM; Kritchevsky SB; Nevitt MC; Pahor M; Satterfield S; Brach JS; Studenski SA; Harris TB
    JAMA; 2006 May; 295(17):2018-26. PubMed ID: 16670410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are different vascular risk scores calculated at midlife uniformly associated with subsequent poor cognitive performance?
    Kesse-Guyot E; Lassale C; Assmann KE; Andreeva VA; Julia C; Blacher J; Fezeu L; Hercberg S; Galan P
    Atherosclerosis; 2015 Nov; 243(1):286-92. PubMed ID: 26409628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores.
    Kaffashian S; Dugravot A; Elbaz A; Shipley MJ; Sabia S; Kivimäki M; Singh-Manoux A
    Neurology; 2013 Apr; 80(14):1300-6. PubMed ID: 23547265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Physical Function with Clinical and Subclinical Brain Disease: The Framingham Offspring Study.
    Camargo EC; Weinstein G; Beiser AS; Tan ZS; DeCarli C; Kelly-Hayes M; Kase C; Murabito JM; Seshadri S
    J Alzheimers Dis; 2016 Jul; 53(4):1597-608. PubMed ID: 27540965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk profile and cognitive function in young, middle-aged, and elderly subjects.
    Joosten H; van Eersel ME; Gansevoort RT; Bilo HJ; Slaets JP; Izaks GJ
    Stroke; 2013 Jun; 44(6):1543-9. PubMed ID: 23640826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative Blood Pressure Exposure During Young Adulthood and Mobility and Cognitive Function in Midlife.
    Mahinrad S; Kurian S; Garner CR; Sedaghat S; Nemeth AJ; Moscufo N; Higgins JP; Jacobs DR; Hausdorff JM; Lloyd-Jones DM; Sorond FA
    Circulation; 2020 Mar; 141(9):712-724. PubMed ID: 31747780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Risk and Cognitive Function in Middle-Aged and Older Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Tarraf W; Kaplan R; Daviglus M; Gallo LC; Schneiderman N; Penedo FJ; Perreira KM; Lamar M; Chai A; Vásquez PM; González HM
    J Alzheimers Dis; 2020; 73(1):103-116. PubMed ID: 31771064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midlife cardiovascular risk factors and late cognitive impairment.
    Virta JJ; Heikkilä K; Perola M; Koskenvuo M; Räihä I; Rinne JO; Kaprio J
    Eur J Epidemiol; 2013 May; 28(5):405-16. PubMed ID: 23532744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex matters in the association between cardiovascular health and incident dementia: evidence from real world data.
    Ponjoan A; Blanch J; Fages-Masmiquel E; Martí-Lluch R; Alves-Cabratosa L; Garcia-Gil MDM; Domínguez-Armengol G; Ribas-Aulinas F; Zacarías-Pons L; Ramos R
    Alzheimers Res Ther; 2024 Mar; 16(1):58. PubMed ID: 38481343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of midlife cardiovascular risk factors on white matter hyperintensity volume and cognition two decades later in normal ageing women.
    Aljondi R; Szoeke C; Steward C; Gorelik A; Desmond P
    Brain Imaging Behav; 2020 Feb; 14(1):51-61. PubMed ID: 30259291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline.
    Bangen KJ; Beiser A; Delano-Wood L; Nation DA; Lamar M; Libon DJ; Bondi MW; Seshadri S; Wolf PA; Au R
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1361-9. PubMed ID: 23601373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.